Is vulnerable elders survey 13 (VES-13) a sensitive and specific screening tool for identifying vulnerable/frail elderly cancer patients compared to full comprehensive geriatric assessment (CGA)?

被引:5
|
作者
Falci, C. [1 ]
Basso, U. [1 ]
Fiduccia, P. [1 ]
Brunello, A. [1 ]
Baretta, Z. [1 ]
Solda, C. [1 ]
Lamberti, E. [1 ]
Bozza, F. [1 ]
Capovilla, E. [1 ]
Jirillo, A. [1 ]
Monfardini, S. [1 ]
机构
[1] IRCCS, IOV, Padua, Italy
关键词
D O I
10.1016/S1040-8428(09)70042-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S19 / S20
页数:2
相关论文
共 46 条
  • [41] Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study
    Liposits, G.
    Ryg, J.
    Skuladottir, H.
    Winther, S. B.
    Moller, S.
    Hofsli, E.
    Shah, C-H.
    Oestergaard, L. Poulsen
    Berglund, A.
    Qvortrup, C.
    Osterlund, P. J.
    Glimelius, B.
    Sorbye, H.
    Pfeiffer, P.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S723 - S724
  • [42] Diagnostic Performance of Screening Tools for Depressive Symptoms in Vulnerable Older Patients with Cancer Undergoing Comprehensive Geriatric Assessment (CGA): Results from the SCREEN Pilot Study
    Tack, Laura
    Maenhoudt, Ann-Sophie
    Ketelaars, Lore
    De Zutter, Jolien
    Pinson, Stefanie
    Keunebrock, Laura
    Haaker, Lorenz
    Deckmyn, Kathleen
    Gheysen, Mathilde
    Kenis, Cindy
    Wildiers, Hans
    Depoorter, Laurence
    Geerts, Pieter-Jan
    Chandler, Rebecca
    Boterberg, Tom
    Schofield, Patricia
    Parris, Christopher N. N.
    Debruyne, Philip R. R.
    CURRENT ONCOLOGY, 2023, 30 (02) : 1805 - 1817
  • [43] Accuracy of the G-8 geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: The ELCAPA-02 study
    Liuu, Evelyne
    Canoui-Poitrine, Florence
    Tournigand, Christophe
    Laurent, Marie
    Caillet, Philippe
    Le Thuaut, Aurelie
    Vincent, Helene
    Culine, Stephane
    Audureau, Etienne
    Bastuji-Garin, Sylvie
    Paillaud, Elena
    JOURNAL OF GERIATRIC ONCOLOGY, 2014, 5 (01) : 11 - 19
  • [44] COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) A SCREENING TOOL FOR TARGET-THERAPY TREATMENT DECISION IN ELDERLY PATIENTS AFFECTED BY METASTATIC RENAL CELL CANCER (MRCC): A PROSPECTIC STUDY
    Simonelli, C.
    Fratino, L.
    Giacalone, A.
    Sartor, I.
    Colussi, A. M.
    Lleshi, A.
    Spazzapan, S.
    Bearz, A.
    Vaccher, E.
    Tirelli, U.
    ANNALS OF ONCOLOGY, 2008, 19 : 210 - 210
  • [45] A MULTICENTER PHASE II RANDOMIZED STUDY OF GEMCITABINE(G) WEEKLY FOLLOWED BY ERLOTINIB(E) AFTER PROGRESSION VERSUS E FOLLOWED BY G AFTER PROGRESSION IN ADVANCED NON SMALL CELL LUNG CANCER(NSCLC)IN VULNERABLE ELDERLY PATIENTS SELECTED WITH A COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) (GFPC*0505)
    Jullian, Herve
    Le Caer, Herve
    Greillier, Laurent
    Corre, Romain
    Crequit, Jacky
    Falchero, Lionel
    Dujon, Celine
    Berard, Henri
    Auliac, Jean B.
    Chouaid, Christos
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1184 - S1184
  • [46] A multicenter phase II ranomized study of gemcitabine (G) weekly followed by eriotinib (E) after progression versus E followed by G after progression in advance non-small cell lung cancer (NSCLC) in vulnerable elderly patients selected with a comprehensive geriatric assessment (CGA) (GFPC*0505)
    Jullian, H.
    Greillier, L.
    Chouaid, C.
    Corre, R.
    Crequit, J.
    Falchero, L.
    Dujon, C.
    Berard, H.
    Auliac, J. B.
    Le Caer, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)